Report Detail
Global Oncology Small Molecule Drugs Market Size, Status and Forecast 2019-2025
- RnM3603622 |
- 19 July, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Other
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths.
In 2018, the global Oncology Small Molecule Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oncology Small Molecule Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Small Molecule Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Roche
Novartis
Pfizer
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
AstraZeneca
Astellas
Merck
Biogen Idec
Eisai
Teva
Otsuka
Ipsen
Gilead Sciences
Exelixis
Market segment by Type, the product can be split into
Chemotherapy Drugs
Immunomodulating Drugs
Targeted Therapy Drugs
Hormonal Therapy
Other
Market segment by Application, split into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oncology Small Molecule Drugs status, future forecast, growth opportunity, key market and key players.
To present the Oncology Small Molecule Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncology Small Molecule Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Chemotherapy Drugs
- 1.4.3 Immunomodulating Drugs
- 1.4.4 Targeted Therapy Drugs
- 1.4.5 Hormonal Therapy
- 1.4.6 Other
- 1.5 Market by Application
- 1.5.1 Global Oncology Small Molecule Drugs Market Share by Application (2019-2025)
- 1.5.2 Blood Cancer
- 1.5.3 Breast Cancer
- 1.5.4 Gastrointestinal Cancer
- 1.5.5 Prostate Cancer
- 1.5.6 Lung Cancer
- 1.5.7 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Oncology Small Molecule Drugs Market Size
- 2.2 Oncology Small Molecule Drugs Growth Trends by Regions
- 2.2.1 Oncology Small Molecule Drugs Market Size by Regions (2019-2025)
- 2.2.2 Oncology Small Molecule Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Oncology Small Molecule Drugs Market Size by by Players
- 3.1.1 Global Oncology Small Molecule Drugs Revenue by by Players (2014-2019)
- 3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Oncology Small Molecule Drugs Key Players Head office and Area Served
- 3.3 Key Players Oncology Small Molecule Drugs Product/Solution/Service
- 3.4 Date of Enter into Oncology Small Molecule Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Oncology Small Molecule Drugs Market Size by Type (2014-2019)
- 4.2 Global Oncology Small Molecule Drugs Market Size by Application (2014-2019)
5 North America
- 5.1 North America Oncology Small Molecule Drugs Market Size (2014-2019)
- 5.2 Oncology Small Molecule Drugs Key Players in North America
- 5.3 North America Oncology Small Molecule Drugs Market Size by Type
- 5.4 North America Oncology Small Molecule Drugs Market Size by Application
6 Europe
- 6.1 Europe Oncology Small Molecule Drugs Market Size (2014-2019)
- 6.2 Oncology Small Molecule Drugs Key Players in Europe
- 6.3 Europe Oncology Small Molecule Drugs Market Size by Type
- 6.4 Europe Oncology Small Molecule Drugs Market Size by Application
7 China
- 7.1 China Oncology Small Molecule Drugs Market Size (2014-2019)
- 7.2 Oncology Small Molecule Drugs Key Players in China
- 7.3 China Oncology Small Molecule Drugs Market Size by Type
- 7.4 China Oncology Small Molecule Drugs Market Size by Application
8 Japan
- 8.1 Japan Oncology Small Molecule Drugs Market Size (2014-2019)
- 8.2 Oncology Small Molecule Drugs Key Players in Japan
- 8.3 Japan Oncology Small Molecule Drugs Market Size by Type
- 8.4 Japan Oncology Small Molecule Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Oncology Small Molecule Drugs Market Size (2014-2019)
- 9.2 Oncology Small Molecule Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Oncology Small Molecule Drugs Market Size by Type
- 9.4 Southeast Asia Oncology Small Molecule Drugs Market Size by Application
10 India
- 10.1 India Oncology Small Molecule Drugs Market Size (2014-2019)
- 10.2 Oncology Small Molecule Drugs Key Players in India
- 10.3 India Oncology Small Molecule Drugs Market Size by Type
- 10.4 India Oncology Small Molecule Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Oncology Small Molecule Drugs Market Size (2014-2019)
- 11.2 Oncology Small Molecule Drugs Key Players in Central & South America
- 11.3 Central & South America Oncology Small Molecule Drugs Market Size by Type
- 11.4 Central & South America Oncology Small Molecule Drugs Market Size by Application
12 International Players Profiles
- 12.1 Roche
- 12.1.1 Roche Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Oncology Small Molecule Drugs Introduction
- 12.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2014-2019))
- 12.1.5 Roche Recent Development
- 12.2 Novartis
- 12.2.1 Novartis Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Oncology Small Molecule Drugs Introduction
- 12.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.2.5 Novartis Recent Development
- 12.3 Pfizer
- 12.3.1 Pfizer Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Oncology Small Molecule Drugs Introduction
- 12.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.3.5 Pfizer Recent Development
- 12.4 Celgene
- 12.4.1 Celgene Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Oncology Small Molecule Drugs Introduction
- 12.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.4.5 Celgene Recent Development
- 12.5 Bristol-Myers Squibb
- 12.5.1 Bristol-Myers Squibb Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Oncology Small Molecule Drugs Introduction
- 12.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.5.5 Bristol-Myers Squibb Recent Development
- 12.6 Amgen
- 12.6.1 Amgen Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Oncology Small Molecule Drugs Introduction
- 12.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.6.5 Amgen Recent Development
- 12.7 Johnson & Johnson
- 12.7.1 Johnson & Johnson Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Oncology Small Molecule Drugs Introduction
- 12.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.7.5 Johnson & Johnson Recent Development
- 12.8 AbbVie
- 12.8.1 AbbVie Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Oncology Small Molecule Drugs Introduction
- 12.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.8.5 AbbVie Recent Development
- 12.9 Sanofi
- 12.9.1 Sanofi Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Oncology Small Molecule Drugs Introduction
- 12.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.9.5 Sanofi Recent Development
- 12.10 Takeda
- 12.10.1 Takeda Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Oncology Small Molecule Drugs Introduction
- 12.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2014-2019)
- 12.10.5 Takeda Recent Development
- 12.11 Eli Lilly
- 12.12 Bayer
- 12.13 AstraZeneca
- 12.14 Astellas
- 12.15 Merck
- 12.16 Biogen Idec
- 12.17 Eisai
- 12.18 Teva
- 12.19 Otsuka
- 12.20 Ipsen
- 12.21 Gilead Sciences
- 12.22 Exelixis
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Oncology Small Molecule Drugs. Industry analysis & Market Report on Oncology Small Molecule Drugs is a syndicated market report, published as Global Oncology Small Molecule Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Oncology Small Molecule Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
